The Centers for Disease Control and Prevention has issued an advisory alerting health care providers, laboratory professionals and others in health care settings of a critical shortage of Becton Dickinson BACTEC blood culture bottles. The shortage could lead to significant disruptions in patient care, including diagnosis delays or make the management of patients with infectious diseases more difficult, according to CDC. The agency is recommending laboratory professionals and clinical leaders in health care facilities that are affected implement plans for conserving available supply and develop options to mitigate the impact on patient care. 
 

Related News Articles

Headline
Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will…
Headline
After incurring damage from Hurricane Helene on Sept. 27, Baxter reports that as of Dec. 19, nearly all of its manufacturing lines in its North Cove, N.C…
Headline
Baxter has resumed production on all of its 3-liter irrigation and peritoneal dialysis solutions manufacturing lines, the company announced Dec. 5. The company…
Headline
The Food and Drug Administration Dec. 4 announced empty IV bags have been added to its Medical Device Shortages List, and that the shortage is estimated to…
Headline
Baxter Nov. 26 announced new allocation levels for multiple IV product groups and advised customers of a one- to two-week lead time for products to flow…
Headline
Supplies of Mo-99/Tc-99M, which are medical radioisotopes used in procedures to diagnose and detect diseases including heart disease and cancer, are…